It was an era of body-moralising in Ireland, when obesity was a personal failure
In a culture that treats bodies as projects to be improved, the idea of simply caring for them feels almost radical
In a culture that treats bodies as projects to be improved, the idea of simply caring for them feels almost radical
Novo blames pricing deal with Donald Trump for downbeat outlook for year ahead but it also faces greater patent expiry issues than its US rival
Dr Muiris Houston: Alongside caution there is excitement about the potential benefits of GLP-1 and related drugs
Radio: Last Word host shares his experiences to good effect, but on Drivetime the new hosts have yet to click
This detailed, eye-opening account is bolstered by an insider look at commercial drug development
Perceptions around weight and beauty have been transformed, with society’s poorest the big losers
It feels like there is an amorality attached to losing weight via GLP-1. Sure, you’re getting thinner, but you didn’t work for it
Offering staff weight-loss drugs can improve productivity and reduce time lost to sickness
Danish drugmaker expects sales and profit growth at lower end of its guidance this year
Wegovy maker’s top investor proposes international board overhaul
Business sustained ‘mounting losses’ amid competition from drugs like Ozempic
High costs are a common worry among users of Ozempic, Mounjaro and other weight-loss drugs, who report varying levels of success
GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say practitioners
Cork singer Lyra on ambition, insecurity and performing for thousands at Croke Park
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices